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Abstract 
Background: Intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine–pyrimethamine (SP), provided 
as part of routine antenatal care (ANC), is one of three malaria-in-pregnancy prevention and control mechanisms rec-
ommended by the World Health Organization (WHO). However, despite high ANC attendance and increased efforts 
to address known obstacles, IPTp uptake figures have remained low. This study aimed to identify and assess barriers 
that continue to impede IPTp uptake in Uganda, in particular for women who attend ANC. The paper focuses on 
supply-side barriers, i.e., challenges relating to the health service provider.
Methods: In-depth interviews were conducted in two regions of Uganda in November 2013 and April/May 2014 
with four different target audiences: seven district health officials, 15 health workers, 19 women who had attended 
ANC, and five opinion leaders. In addition, a document and record review was carried out at four health facilities.
Results: Guidelines with regard to IPTp provision in Uganda have been shown to be inconsistent and, at the time of 
the research, did not reflect the most recent WHO policy recommendation. There is a lack of training and supervision 
opportunities for health workers, resulting in poor knowledge of IPTp guidelines and uncertainty about the safety and 
efficacy of SP. ANC is not consistently offered in health facilities, leading to some women being denied services. While 
strengthening of the supply chain appears to have reduced the occurrence of stock-outs of SP in public facilities, 
stock-outs reportedly continue to occur in the private sector. There are also sources of data inaccuracy along the data 
recording and reporting chain, limiting policy makers’ ability to react adequately to trends and challenges.
Conclusions: Given the high ANC attendance rates in Uganda, supply-side barriers are likely to account for many 
missed opportunities for the provision of IPTp in Uganda. Improvements will require consistent provision of ANC, 
implementation of current WHO IPTp policy recommendations, supply of SP to the private sector, availability of clear 
guidelines, as well as improved training and supervision for health workers. Improving facility and district-level record-
ing and reporting will further strengthen the country’s ability to address uptake of IPTp.
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Background
Malaria in pregnancy can cause serious harm to the 
health and well-being of both mother and child. It can 
lead to maternal anaemia, which is estimated to con-
tribute to between 10 and 25 % of all maternal deaths in 
endemic areas [1]. Malaria in pregnancy also increases 
the risk of miscarriage and intra-uterine growth restric-
tion, as well as pre-term and low birth weight delivery 
[2]. Each year, 27.6 million pregnancies leading to live 
births occur in malaria-endemic areas in Africa and it 
is estimated that, in the absence of preventive interven-
tions, 12.4 million of them would have been exposed to 
malaria infection [3].
The World Health Organization (WHO) recommends 
three strategies for the prevention and control of malaria 
in pregnancy: (i) effective case management for malaria 
illness and anaemia; (ii) use of insecticide-treated nets; 
and, (iii) intermittent preventive treatment in pregnancy 
(IPTp) with sulfadoxine–pyrimethamine (SP) [4].
IPTp involves the administration of curative doses of an 
anti-malarial drug to pregnant women residing in areas 
of moderate or high transmission in Africa, typically as 
part of the focused antenatal care (ANC) package. While 
SP is no longer recommended for the treatment of con-
firmed clinical cases of malaria, the drug is still consid-
ered the most efficacious anti-malarial for preventive use 
in pregnant women [5].
Previously, WHO guidelines recommended at least 
two doses of SP after quickening at the second and third 
scheduled ANC visit [4]. Since 2012, WHO recommends 
IPTp with SP for all pregnant women at each scheduled 
ANC visit, except during the first trimester and pro-
vided that doses are given 1 month apart. IPTp should be 
administered as directly observed therapy (DOT). Preg-
nant women who are human immunodeficiency virus 
(HIV)-positive and who receive co-trimoxazole prophy-
laxis should not be given IPTp [5].
Despite high use of ANC services in many countries 
of sub-Saharan Africa, in 2014 only 40 % of women in 36 
reporting countries received two doses of IPTp and 17 % 
received three or more doses [6], suggesting that a large 
number of opportunities to provide IPTp during ANC 
continue to be missed. A broad range of obstacles to the 
effective provision of ANC and IPTp have been discussed 
in the literature [7, 8], including issues relating to lead-
ership and coordination, human resources, supply chain, 
and service delivery.
This study sought to identify and assess barriers that 
continue to impede uptake of IPTp in Uganda, despite 
high ANC uptake and increased efforts by govern-
ment and implementation partners to address some of 
the commonly described bottlenecks. Using qualitative 
methods, this research attempted to gain an in-depth 
understanding of how key informants (district health offi-
cials, health workers, opinion leaders, pregnant women, 
and mothers) perceive the provision of IPTp and how 
this could affect its uptake, in particular for those women 
who do attend ANC. Accuracy and quality of available 
facility and district-level data were explored through a 
review of documents and records relating to ANC and 
IPTp. The research was intended to inform the develop-
ment of a pilot intervention to increase uptake of IPTp.
This paper focuses on key challenges identified relat-
ing to supply-side issues, i.e., those challenges relating 
to the health service provider, including barriers relating 
to accessibility due to availability of services, affordabil-
ity due to service charges, and acceptability from health 
workers’ point of view [9]. The findings of the document 
and record review are also reported here, as accuracy and 
quality of available coverage data will affect policy makers’ 
and service providers’ ability to gauge the extent of the 
problem and react appropriately to challenges. Demand-
side barriers will be presented in a separate paper.
Methods
Study design
The study involved qualitative elements and a document 
and record review. Reporting of the qualitative study 
methods follows the consolidated criteria for reporting 
qualitative research (COREQ) [10].
Study setting
ANC and IPTp in Uganda
All of Uganda’s population is thought to live in areas of 
high malaria transmission [6]. More than 600,000 preg-
nancies are at risk from malaria infection each year 
[3]. Countrywide IPTp programme implementation in 
Uganda started in 2001 [11]. As in most countries, the 
treatment is provided to pregnant women as part of rou-
tine ANC visits. The various IPTp guidelines and policies 
in use in Uganda have been found to be “inconsistent or 
unclear” [12] and, at the time of the research, did not 
yet reflect the latest WHO policy recommendation of 
monthly administration from the second trimester, which 
was only formally adopted in May 2016.
According to Demographic and Health Survey data, 
coverage of at least two doses of IPTp was 25 % in 2011 
[13], down from 32 % in 2009 [14]. Approximately 90 % 
of women visited ANC at least twice [13]. Recognizing 
the challenge, government and implementation partners 
have stepped up efforts to increase uptake of IPTp. How-
ever, coverage gaps remain.
Study regions and districts
Taking into account feasibility with regard to time and 
budget, two regions of Uganda were selected, Eastern 
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and West Nile (see Fig. 1), which represent a broad range 
of the country’s geographical, linguistic and ethnic diver-
sity. The two regions were also selected because conduct-
ing the study in those regions was expected to provide 
an insight into barriers to and enablers of IPTp uptake, 
as, according to the most recent Uganda Demographic 
Health Survey for which data are available, they were the 
regions reporting the highest and lowest uptake of IPTp. 
In Eastern, 36  % of women reported having received at 
least two doses of IPTp, while this figure was only 21 % 
in West Nile [13]. This may be a reflection of the fact that 
Eastern has benefited from several malaria prevention 
and control programmes, whereas West Nile is among 
those regions that have historically received lower levels 
of implementation partner support.
Within each region, one predominantly urban and one 
predominantly rural district were purposively selected 
for inclusion in the study sample. Table  1 presents an 
overview of IPTp and ANC uptake figures for the 2 years 
preceding data collection (2011 and 2012) from the study 
districts and regions. The data were extracted from the 
Republic of Uganda’s Health Management Informa-
tion System (HMIS). It is noticeable that the pattern of 
high uptake of IPTp in Eastern and low uptake in West 
Nile found by household surveys is not consistently 
reflected in the HMIS data, which are based on reports 
from health facilities. Note, however, that an assessment 
of health facility data quality in Uganda carried out by 
WHO in 2011 concluded that “intervention coverage 
estimates are often poor” [15]. This conclusion is sup-
ported by the results of the document and record review 
carried out as part of this study. The study team did not 
have access to HMIS data at the time of selecting study 
regions and districts.
Health facilities
In each of the four study districts, two health facilities 
were selected, representing all levels of health centres 
(II, III, IV and hospital) that provide ANC services in 
Uganda. Only public and private not-for-profit (PNFP) 
facilities were selected, as those types of facilities were 
expected to experience similar challenges. The Ministry 
of Health does not provide specific support on IPTp to 
private for-profit health facilities and this type of facility 
was therefore excluded from the sample.
Health facilities were selected based on convenience, 
but ensuring that the respective number of types of facili-
ties included in the sample approximately corresponded 
Fig. 1 Map of the Republic of Uganda. Study regions highlighted in 
dark grey
Table 1 Antenatal care and IPTp uptake data (%) in study districts, 2012–2013 (Source: Health Management Information 
System, Republic of Uganda)
a ANC1: First antenatal care visit; denominator: expected pregnancies (5 % of total population in the area)
b ANC4: Fourth antenatal care visit; denominator: expected pregnancies (5 % of total population in the area)
c IPT1: First dose of IPTp; denominator: ANC1
d IPT2: Second dose of IPTp; denominator: ANC1
ANC1a ANC4b IPT1c IPT2d
2011 2012 2011 2012 2011 2012 2011 2012
Uganda 90 84 29 28 58 79 44 50
Eastern 73 67 18 18 79 83 51 52
 Urban study district 57 66 15 29 97 96 70 76
 Rural study district 43 61 6 9 78 93 66 55
West Nile 46 57 18 22 83 86 59 62
 Urban study district 61 101 19 36 76 81 50 54
 Rural study district 20 22 13 11 92 92 71 69
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to the proportion of this type of facility in the country 
[16]. One of the two health facilities sampled in each 
district was purposively selected for the document and 
record review, again ensuring a mix of different types of 
health facilities were represented. Originally, two PNFP 
facilities had been selected in line with this type of facil-
ity’s overall proportion among health facilities in the 
country. However, one of the PNFP facilities originally 
selected, a health centre II, was found to be no longer 
operational shortly before the research team’s planned 
visit and an alternative public health centre II in the 
same district was selected at short notice. See Fig. 2 for 
an overview of the types of health facilities selected per 
study district.
Participant selection
A total of 46 in-depth interviews were carried out. None 
of the selected interviewees who were approached by the 
field team refused to be interviewed. Table 2 presents an 
overview of in-depth interviews conducted per type of 
respondent, as well as how interviewees were approached 
and where the interviews took place. Taking into account 
available time and budget and recognizing the systematic 
selection of study regions, districts, health facilities, and 
participants, this sample size was considered sufficient to 
adequately explore the research questions and to arrive at 
valid conclusions and recommendations.
District health officials
Two district health officials per district were selected 
in consultation with the District Health Officer, based 
on their involvement in malaria in pregnancy planning, 
implementation and reporting. A total of seven inter-
views were conducted, as only one suitable district official 
was available in one district in West Nile during data col-
lection. Interviewees at the district level included Malaria 
Focal Persons, as well as staff in charge of maternal and 
newborn health, supply chain management, health edu-
cation, and HMIS data.
Health workers
At each health facility, two health workers were selected 
in consultation with the facility in-charge based on their 
involvement in provision and oversight of ANC services. 
One was generally the acting facility in-charge and the 
other was a midwife. In one facility in West Nile only one 
potential interviewee was available on the day the field 
team visited; hence, a total of 15 health workers were 
interviewed.
Women
During a first round of data collection, pregnant women 
or women who had given birth during the previous 
12  months and who had attended ANC at least once 
were selected from health facilities’ ANC registers with 
the help of a health worker. Two women were selected 
per facility, one who was still pregnant and one who had 
recently given birth. Where possible, the team selected 
one woman who lived within walking distance from the 
facility and one woman from the edge of the facility’s 
catchment area. However, it was difficult to apply this 
criterion in the field and information about distance from 
the health facility was not captured consistently. A total 
of 16 women were interviewed initially.
During analysis of the data from the first round of data 
collection, it emerged that all women interviewed were 
frequent ANC attenders and held largely positive views 
of IPTp. It was felt that health workers’ involvement in 
identifying suitable interviewees may have biased the 
data collected. To obtain a more comprehensive under-
standing of women’s perceptions, a second round of 
data collection was carried out specifically to interview 
women who had attended ANC, but had not received a 
full course of IPTp despite being eligible at the time of the 
ANC visit. Fifteen women were therefore identified from 
facilities’ ANC registers by the field researchers without 
any involvement from health workers. Although the team 
intended to carry out four additional interviews, only 
three of these 15 women fit the inclusion criteria and 
were subsequently interviewed. All three had recently 
given birth. The remaining 12 women either reported 
that they had in fact received IPTp or that they had not 
been eligible to receive IPTp at the time of the ANC visit 
in question.
Opinion leaders
During the second round of data collection, the team also 
conducted five additional in-depth interviews with opin-
ion leaders who were considered influential in shaping 
Fig. 2 Type of health facilities visited per study district. HC health 
centre, PNFP private not-for-profit. Health facilities selected for the 
document and record review have been highlighted in bold
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communities’ perceptions and practices with regard to 
ANC and IPTp. Opinion leaders were selected in con-
sultation with the sub-county Secretary for Health and 
included traditional birth attendants, a community coun-
cillor, a teacher, and a retired midwife.
Data collection
Field work
The first round of qualitative data collection was con-
ducted during November 2013 by CR and eight field 
researchers. Five of the field researchers were female, 
three were male; all were university or college graduates 
with some previous field research experience and rel-
evant local language skills. Prior to data collection, field 
researchers attended a 5-day training course on malaria 
in pregnancy and qualitative research techniques, which 
was conducted by CR. The second round of data collec-
tion was carried out over a period of 8 days in April and 
May 2014 by CR and three of the field researchers who 
had been involved in the first round of interviews. Only 
two out of the original four study districts were visited 
for the additional interviews: the urban district in East-
ern region and the rural district in West Nile. Due to con-
straints in terms of time and logistics, this was considered 
sufficient as results from the first round of data collection 
did not differ widely between urban and rural districts 
within the same region.
Interviews lasted between 45 and 75  min. District 
health officials, health workers and opinion leaders were 
interviewed in English, while interviews with pregnant 
women and mothers were conducted in the languages 
spoken in the study districts (Ateso, Lugbara and Madi). 
All in-depth interviews were audio-recorded. To ensure 
quality, researchers discussed experiences, challenges 
and lessons learned in daily briefing and debriefing ses-
sions while in the field with CR.
The document and record review was carried out by 
PM concurrently with the first round of qualitative data 
collection. At each selected facility, the following records 
for the periods May to October 2012 and May to October 
2013 were reviewed:
  • ANC register to establish number of first (IPT1) and 
second (IPT2) doses of IPTp provided and number of 
first (ANC1) and fourth (ANC4) visits;
  • Monthly reports filed by the facility to the district level 
to compare IPTp and ANC data reported to the dis-
trict level with data recorded in the facility’s register;
Table 2 In-depth interviews conducted per type of respondent
Type of respondent Number of respondents Approached by Location of interview
District health officials
 Malaria Focal Persons 3 District health officer, 1 week prior to 
research team’s visit to district
Respondents’ usual place of work
 Assistant District Health Officer (Mater-
nal and Child Health)
1
 Health Educator 1
 Health Management Information Sys-
tem Focal Person
1
 Stores Assistant 1
Total district health officials 7
Health workers
 In-charges 7 Facility in-charge, 1 week prior to 
research team’s visit to facility
Respondents’ usual place of work
 Midwives 8
Total health workers 15
Women
 Pregnant and received IPTp 8 Researcher on day of visit to community Respondents’ home or health facility
 Recently given birth and received IPTp 8
 Recently given birth and did not receive 
IPTp
3
Total women 19
Opinion leaders
 Traditional birth attendants 2 Researcher on day of visit to community Respondents’ home
 Community councillor 1
 Teacher 1
 Retired midwife 1
Total opinion leaders 5
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  • SP stock cards to determine availability of SP for the 
provision of IPTp.
Review of records covering two equivalent 6-month 
periods was considered sufficient to allow the team to 
draw conclusions in terms of trends unaffected by sea-
sonal variances. The researcher also noted gestational 
age of ANC attendees at the time of IPTp administra-
tion. However, this information was not systematically 
captured by the researcher. Gaps and inconsistencies in 
the reviewed documents were discussed informally with 
health workers while at the facility.
Data collection tools
Interviews were conducted using semi-structured inter-
view guides (see Additional files 1, 2, 3, 4), which were 
developed by CR, KG, RK, and SGS based on a thorough 
review of the literature and experience implementing 
malaria in pregnancy prevention interventions. Interview 
guides were pre-tested, except for the guide for inter-
views with opinion leaders, which was largely based on 
guides used previously with the other target audiences. 
Table  3 summarizes the topics relating to supply-side 
challenges covered by the interview guides for the dif-
ferent target audiences. Note however, that all interview 
guides contained open-ended questions about respond-
ents’ general perceptions of IPTp and the reasons behind 
the low uptake of the service, so respondents were not 
limited to elaborating on the topics covered by specific 
questions only.
For the document and record review, Excel spreadsheet 
software (Microsoft Corp) was used to capture informa-
tion from facilities’ registers and reports.
Transcription and translation
Interviews conducted in English were subsequently tran-
scribed verbatim, whereas those conducted in a local 
language were translated directly into English from the 
audio recording by the researcher who had conducted 
the interview. Field researchers were also required to take 
notes during the interview and to include non-verbal 
clues in the transcripts.
Data analysis
Interview transcripts were managed using NVivo 10 
qualitative analysis software (QSR International) and 
analysed by theme. An initial coding frame was devel-
oped by CR, KG and RK based on insights from a litera-
ture review and preliminary analysis of a sample of five 
interview transcripts with different types of respond-
ents. CR subsequently coded all transcripts, discussing 
and agreeing proposed changes and additions to the 
original coding frame with KG and RK. Themes were 
analysed by code and summarized in a comprehen-
sive study report. Data collected for the document and 
record review were synthesized and analysed by PM, 
and subsequently reviewed and discussed with CR, KG 
and SGS.
Results and discussion
Stakeholders and coordination
District officials in Eastern region listed a range of non-
governmental stakeholders with an interest in ANC and 
malaria in pregnancy. They emphasized the positive role 
implementation partners play particularly with regard to 
providing resources, commodities, capacity building, and 
monitoring and evaluation. While planning and coordi-
nation mechanisms between districts and implementa-
tion partners were generally characterized as strong and 
well established, it was also repeatedly pointed out that 
there is no such coordination involving stakeholders 
from overlapping disease programmes such as HIV:
District official 1: If—maybe—majority of them—
like HIV. That’s where they now are. They are there. 
If maybe we could talk with them and integrate it 
there. Because malaria has an effect with HIV posi-
tive persons. If they talk to— maybe they could inte-
grate. But most of their activity that I see, there’s no 
malaria.
Table 3 Supply-side topics covered by interview guides
X denotes that this topic was covered by a specific question or probe in the interview guide
Topic District health officials Health workers Women Opinion leaders
Role/responsibilities X X – X
Stakeholders and coordination X – – –
Policies and guidelines X X – –
Provision of ANC services – X X X
Supply chain X X X X
Capacity building – X – –
Health worker knowledge and perceptions of IPTp – X – –
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This echoes concerns raised in the literature that failure 
to create and maintain strong links between disease-spe-
cific programmes can lead to fragmented and ineffective 
service delivery [17]. In the case of IPTp, this is particu-
larly significant as it cuts across the remit of malaria, 
maternal health and potentially other stakeholders, such 
as those focused on HIV or immunization [18].
District-level respondents in West Nile on the other 
hand generally reported a lack of support from imple-
mentation partners and pointed out that there is little 
coordination between the districts and the few imple-
mentation partners that do have a presence in the region:
District official 5: Well – the organization which, 
err, handles aspect of – specific organization which 
addresses aspect of malaria in pregnancy is – not so 
far well streamlined.
Policies and guidelines
Consistency and relevance of guidelines
For policies to be implemented effectively, they need to 
be communicated and interpreted in a consistent manner 
across the health system [18]. A review of national-level 
malaria in pregnancy documents in Uganda carried out 
in 2013 revealed that guidance with regard to timing and 
dosage of IPTp was often inconsistent, with some docu-
ments specifying the timing of doses in terms of weeks 
of pregnancy, while others use months and some do not 
specify timings at all [12]. It was also not clear whether 
the time windows specified for the provision of IPTp are 
mandatory or whether they merely indicate when IPTp 
should ideally be administered. Similarly, there was a lack 
of clarity as to whether the guidelines define two as the 
maximum or simply the recommended number of doses 
a woman should receive.
None of the district officials and health workers inter-
viewed was aware of the existence of conflicting guide-
lines. Most stated that the guidelines are clear and easily 
understood. Only one district official implied that ambig-
uous or outdated guidelines may cause confusion among 
health workers over when to offer IPTp to pregnant 
women attending ANC:
District official 2: Then maybe one can receive that 
one who is at 36. What do I do? They told me 28. You 
are late. You have missed out.
Even though the majority of district officials and health 
workers were not aware of the issue, the existence of 
inconsistent IPTp guidelines is likely to contribute to 
missed opportunities for the provision of the treatment 
to pregnant women, as health workers may not provide 
IPTp to women they incorrectly believe not to be eligi-
ble or because they prefer not to provide it because they 
are unsure about whether a woman is eligible. Similarly, 
using guidelines that are not in line with current WHO 
recommendations means that women will not receive 
optimum protection from malaria in pregnancy. It has 
been shown that inconsistent, complex or outdated 
guidelines contributed to low IPTp coverage in Tanzania 
and Mali [19, 20].
Male involvement in ANC
The Republic of Uganda’s Ministry of Health aims to 
encourage male partners to accompany pregnant women 
to ANC. Many respondents across all types of respond-
ents suggested that this can lead pregnant women 
to assume they will not receive services if they can-
not attend with their partners. It was also reported by 
respondents from all target audiences that some women 
will delay attendance because their partners are unable or 
unwilling to accompany them:
Opinion leader 5: Sometimes when the pregnant 
women go without their partners, they are sent back 
and such a woman will refuse to go again unless the 
partner is there—and when the partners is far from 
her, the woman will not even step the health [facil-
ity] again.
Several opinion leaders reported that women who did 
not attend with their husbands had been denied ANC 
services by health workers. While none of the women 
interviewed confirmed this, several indicated that they 
had been treated differently depending on whether or not 
their partners had accompanied them. For example, they 
reported that women attending with their partners had 
been seen to first, while those attending without their 
partners had been made to wait:
Woman 5: The two visits I made with my husband 
we were attended quickly and we didn’t take long 
at the facility, but when I went alone, I took long, 
because those with partners are attended first.
Male involvement in maternal and child health is a cru-
cial factor in improving maternal and child health ser-
vices [21] and should be encouraged, but health workers 
should be discouraged from giving preferential treatment 
to women who attend with their partners, which may not 
be possible for many.
Provision of ANC services
Availability and accessibility of ANC services
Despite established standard procedures, ANC ser-
vice delivery appeared to differ from facility to facility 
in the units visited. While some health facilities were 
said to provide daily ANC services in line with national 
guidelines, health workers, women and opinion leaders 
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reported or implied that other facilities only offer ANC 
on certain days of the week, focusing on other services 
like family planning or immunization on the remaining 
days:
Woman 16: They said each institution has different 
rules and regulations and at such a time they do 
other things, not to attend to mothers now.
District officials stated that this was particularly com-
mon in lower-level facilities, some of which reportedly do 
not offer ANC services at all due to a lack of funding or 
qualified staff.
Many opinion leaders pointed out that low staff levels 
frequently lead to midwives being unable to attend to all 
ANC clients on a given day and refusing services to some 
women:
Opinion leader 2: So these women from the village, 
they come footing up to the dispensary. Now, reach-
ing there, they will get the nurses already selected 
twenty. The first twenty –
Opinion leader 1: Are the ones they handle.
Opinion leader 2: They will tell the majority, “Go 
back and come back next week.” […] Because now, 
for them they will always select the first twenty.
Several opinion leaders related that midwives some-
times refuse to attend to women they perceive to be inad-
equately dressed: 
Opinion leader 2: You know like these village women, 
they come on their skirts, what – like that [indicates 
tight fitting skirt]. So these nurses want, “You come 
when you are putting on your maternity [refers to 
a wide, loose-fitting skirt conventionally worn by 
pregnant women]. You have a leso [a cloth wrapped 
around the waist], we will attend to you.”
It was suggested by both district officials and opinion 
leaders that some women may delay ANC attendance to 
avoid embarrassment or because they do not have the 
resources to buy a maternity dress, which may result 
in late or irregular ANC attendance and hence missed 
opportunities for the provision of IPTp. Non-availability 
or refusal of ANC services by health workers not only 
leads to women not receiving vital services, including 
IPTp, when they visit the health facility, but those prac-
tices are also likely to have a negative effect on uptake 
of ANC and IPTp in the longer term, as they will shape 
women’s and communities’ perception of ANC services.
Job satisfaction
Opinion leaders, women and district officials speculated 
that low job satisfaction among front-line health workers 
may contribute towards poor attitude and unprofessional 
behaviour among ANC staff. While district officials sug-
gested that staffing levels were generally adequate, many 
health workers stated that there were too few staff in 
ANC and that midwives’ workload was immense. This 
is in line with reports of widespread dissatisfaction with 
working conditions among health workers in the litera-
ture [22, 23].
Many respondents from all target audiences stated that 
they had heard of cases of unprofessional behaviour on 
the part of health workers. They frequently commented 
on the effect of poor staff attitude on women’s percep-
tions of ANC, linking negative experiences to low uptake 
or late ANC attendance:
District official 1: Maybe also the other factor is—I 
cannot fear to mention this—is the attitude of the 
health workers—the ANC midwives. Their treat-
ment to the – to the mothers. Also—possibly also can 
make them shy away.
Disrespectful and rude health worker behaviour was 
reported specifically in the case of women who miss ANC 
appointments, as well as for women who are perceived as 
initiating ANC too early or too late. Since those are par-
ticularly likely to miss out on the recommended number 
of doses of IPTp, health workers’ brusqueness with this 
type of client is worth noting. This reflects findings of 
previous studies conducted in Uganda [24], which cited 
instances of mistreatment of clients by health workers 
and found that clients’ satisfaction levels with health ser-
vice are low. However, most of the women interviewed, 
regardless of whether or not they had been selected with 
the help of a health worker, stated that they had generally 
been treated politely and respectfully during their own 
ANC visits:
Woman 2: In this health centre, you are welcomed 
and treated well. They mind of your health and the 
wellbeing of pregnant women.
Incentives
Many respondents referred to the provision of free mos-
quito nets, usually during a pregnant woman’s first visit, 
as a major incentive to attend ANC:
District official 5: But, you’ll realize that some of 
these indicators just improve—sometimes they just 
improve by themselves when a cer—especially when 
certain incentives are there. Like, recently, there is 
net—because of the net, the enrolment has started 
changing.
This was confirmed by many of the women interviewed:
Researcher: Is there anything else that encouraged 
Page 9 of 16Rassi et al. Malar J  (2016) 15:341 
you to go for ANC that first time?
Woman 3: Yes, I went to the hospital they gave me 
my net I came back to sleep under my net.
A number of respondents from one study district 
reported that mosquito nets for ANC had not been avail-
able for a number of months. The shortage was repeat-
edly linked to a universal net distribution campaign, 
which may have resulted in available nets being chan-
nelled away from ANC. Respondents expressed concern 
that this campaign could result in lower ANC uptake 
as receiving a net will no longer be seen as an incentive 
for attending ANC. Other respondents felt that the lack 
of nets for ANC could lead to reduced protection from 
malaria for some pregnant women, as the nets distrib-
uted through the campaign might be reserved for use by 
men in a context where pregnant women traditionally do 
not share a bed with their partners. Continuing the pro-
vision of incentives was one of the most frequently men-
tioned recommendations in terms of maintaining high 
levels of ANC attendance.
Supply chain
Availability of SP
District health officials and health workers in both study 
regions reported that the supply chain had been signifi-
cantly strengthened through the efforts of the Ministry of 
Health and implementation partners in recent years and, 
as a result, stock-outs of SP no longer occur. Women and 
opinion leaders also reported that drugs for IPTp, unlike 
many drugs for other purposes, were typically available 
in the health facilities. This was confirmed by the review 
of SP stock cards, which did not find stock-outs during 
the 6-month period under review in the public facilities 
visited. This is a very encouraging finding since shortages 
and stock-outs of SP had been identified as major bot-
tlenecks to IPTp provision in many countries, including 
Uganda [11, 22, 25]. The findings from this research are 
in line with those of a recent comparative study in Ghana, 
Kenya and Malawi, which did not find evidence of drug 
shortages [26].
However, PNFP facilities do not seem to have ben-
efited from supply chain strengthening efforts in equal 
measure. Under the current system, National Medical 
Stores, an autonomous government corporation tasked 
with ensuring drug supply in the public health sector, 
provides SP free of charge to public facilities, but private 
and PNFP facilities are required to procure SP from Joint 
Medical Stores, a not-for-profit wholesale enterprise 
that sells pharmaceuticals and equipment to the private 
health care sector. As funds to procure SP are often lim-
ited, frequent stock-outs of the drug were reported by 
health workers at the PNFP facility visited for this study. 
This was also confirmed more generally by district health 
officials for PNFP facilities in their district. Where SP is 
available, health workers at this facility described how 
they are forced to choose between two scenarios: either 
they require women to pay a fee for the provision of IPTp 
(against a national guideline which requires facilities to 
provide IPTp free of charge) or they provide IPTp for free 
to clients, but at a financial loss to the facility. Either sce-
nario is likely to negatively affect IPTp uptake, particu-
larly given the significant role of the private health care 
sector in Uganda [27].
A number of respondents emphasized the negative 
impact of non-availability of drugs on women’s and com-
munities’ perceptions of ANC. In Eastern region, the 
term used for attending ANC in the local language liter-
ally translates as going to take the medicine, so in this con-
text failure to provide medication may be equated with 
failure to provide good ANC in general:
Health worker 7: Because now our mothers are used 
– […] It motivates them that when you are going to a 
facility, there is that saying – they say that, “alosingo 
amat ekiya” [Ateso for ‘I am going to take medicine’], 
so if she goes away without any medicine, it will 
imply that her visit was not fruitful, so it demoral-
izes them.
Availability of water and cups
District officials and health workers overwhelmingly 
reported that water, jerry cans, cups, and water puri-
fication tablets had been provided in sufficient quan-
tities. The majority of the women interviewed in both 
study regions also reported that clean cups and water 
had been available when they were offered IPTp. This 
is another encouraging finding, as research carried out 
in Uganda in 2011 had found that, while 74 % of facili-
ties had safe water ready for use in ANC, only 47 % had 
adequate cups [28]. Lack of safe water and cups has also 
been reported in studies in other African countries [22, 
29].
Capacity building
Individual supervision
Formal supervision or mentoring mechanisms for ANC 
staff were only reported by health workers at one of the 
eight facilities visited. More typically, health workers 
related that they can discuss complex cases with sen-
ior staff on an ad hoc basis if required. However, several 
health workers felt that such opportunities were rare:
Health worker 11: Actually I don’t know how I 
should say it has not really been so much there. It is 
just once in a while.
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Training
In terms of receiving formal classroom training on IPTp, 
health workers were evenly split: about one-third indi-
cated they had received training on IPTp; one-third said 
they had not been trained on IPTp specifically, but IPTp 
had been covered as part of a broader training, for exam-
ple on treatment of malaria; and, one-third stated they 
had never received any formal training on IPTp. There 
was a consensus among health workers and district offi-
cials that training is an important factor in ensuring 
quality of service delivery, as it enables health workers to 
refresh their knowledge and keep track of scientific pro-
gress. However, it was also pointed out that classroom 
training can be disruptive to service provision. A num-
ber of health workers expressed a preference for less dis-
ruptive training methods such as on-the-job training or 
mentoring:
Health worker 11: I think the training would be bet-
ter on job here – not carrying people somewhere, but 
it would be better here just on job. Like it is an ante-
natal day, mothers are also there – we get mothers 
so – kind of mentorship I think it would be better.
Lack of supervision and training on IPTp is likely to 
contribute towards health workers’ poor understanding 
and knowledge of current IPTp guidelines. This confirms 
the results of several studies that identified a lack of effec-
tive training and individual supervision as barriers to the 
provision of IPTp [22, 30]. Conversely, training health 
workers has been shown to increase uptake of IPTp [31]. 
In Uganda, a review of relevant materials found that no 
pre-service education materials for midwives covering 
malaria in pregnancy or IPTp existed in 2013 [12].
Health worker knowledge and perceptions of IPTp
Health worker knowledge
When asked to outline the current guidelines for IPTp pro-
vision, it transpired that there was wide variation between 
health workers, particularly in terms of their knowledge 
and interpretation of the recommended timing of IPTp 
administration. Most health workers correctly speci-
fied that the first dose of IPTp should not be given in the 
first trimester, with 16  weeks mentioned by a majority of 
respondents as the lower limit. Week 20, 24, 26 and 28 were 
variously mentioned as the upper limit. There was similar 
variance in terms of the timing of IPT2, where the lower 
limits mentioned ranged from week 16 to week 34, with 
upper limits mentioned ranging from week 28 to 36. Very 
few health workers pointed out that IPTp can be given up 
to the time of delivery and two explicitly stated that IPTp 
should not be given during the later stages of a woman’s 
pregnancy.
Most health workers implied that they treat the time 
windows specified by the guidelines as recommendations 
only. However, several health workers suggested that the 
time windows are mandatory, which means opportuni-
ties for the provision of IPTp may be missed if women 
present for ANC at other times. Similarly, the major-
ity of health workers appeared to interpret the current 
guidelines as specifying that a woman should not receive 
more than two doses. In light of current evidence that 
three or more doses of SP are associated with fewer low 
birth weight deliveries compared to the standard two-
dose regimen [32], this means women do not currently 
receive optimum protection from the effects of malaria in 
pregnancy. Health workers’ confusion about timing and 
dosing has been cited as a barrier to IPTp provision by 
a number of studies in a range of African countries [33, 
34]. Inconsistent and unclear policies and guidance [12] 
are likely to contribute to the inadequate knowledge and 
differing interpretations of the guidelines among health 
workers.
Observations made as part of the document and record 
review revealed that provision of IPTp appears to vary 
between facilities as well as between individual health 
workers. In some health facilities, pregnant women were 
generally not offered IPTp until after week 22 of their 
pregnancies even if they had initiated ANC earlier. Simi-
lar variations were found at the later stages of pregnancy, 
with women not being offered IPTp if they reported or 
returned after week 36. All the practices observed create 
missed opportunities for the provision of IPTp, which is 
considered safe from week 13 up to the time of delivery, 
despite previous concerns about the safety of administra-
tion of SP late in pregnancy [5].
Safety and efficacy
All district officials and health workers demonstrated an 
understanding of malaria in pregnancy as a health risk to 
mother and child. They generally agreed that in order to 
maximize protection, pregnant women should take pre-
ventive medication in addition to practicing protective 
behaviour, such as sleeping under a mosquito net. While 
most district officials and health workers were broadly 
supportive of the concept of IPTp, some appeared to 
have reservations with regard to its efficacy and safety. 
This was based mainly on the observation that cases of 
malaria in pregnancy persist despite IPTp administration 
over several years:
Health worker 11: But about how efficient, I have 
some questions about it and am not really very sure 
if it is really efficient. As I told you before, much as 
mothers take it, they still suffer from malaria. So my 
concern is in that area how efficient it works.
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A small number of health workers also expressed con-
cerns about the side effects of SP, particularly if taken on an 
empty stomach. Several health workers mentioned that SP 
can also be used for the treatment of symptomatic malaria; 
however, a few pointed out that it is no longer used as a 
first-line anti-malarial. One interviewee indicated that 
the reasons behind discontinuing SP for the treatment of 
malaria while retaining it for IPTp were not clearly com-
municated, raising doubts with regard to the drug’s safety 
and efficacy. Two health workers in West Nile on the other 
hand indicated that they still use SP to treat symptomatic 
malaria because they feel it is more efficacious or better 
tolerated than other available anti-malarial drugs.
About half the health workers interviewed stated that 
they were not aware of or had never been confronted 
with safety issues or side effects related to IPTp admin-
istration. The other half indicated that women did occa-
sionally experience side effects after receiving IPTp and 
there were also concerns over allergic reactions to SP. 
However, most of the health workers who voiced concern 
elaborated that side effects and allergic reactions were 
rare and typically mild:
Health worker 12: Well, there is this slight side effect 
of having maybe headache, dizziness—the dizzi-
ness is there. Maybe nausea—feeling like vomiting. 
But we have not got very serious side effects which is 
adverse effect—adverse —which is worse side effect. 
We have not got it. But this one of nausea—feeling 
like vomiting—abdominal pain—they complain. But 
it’s mild. It’s mild. Not very serious yet.
Only two midwives stated that the side effects can be 
serious, one of them because she herself had experienced 
them after taking SP.
In order to ensure health workers’ compliance with 
IPTp provision guidelines, it will be important to provide 
information about the efficacy and safety of SP. While 
none of the health workers interviewed stated that they 
do not provide IPTp because they doubt the drug’s effi-
cacy and safety, it cannot be ruled out that this may con-
tribute to low IPTp coverage.
Offering IPTp
All health workers interviewed reported that if SP is 
available and they have determined a client’s eligibility, 
they always offer IPTp. A majority of the women inter-
viewed also indicated that they had been offered IPTp 
when they attended ANC. However, the three women 
who were interviewed because they had not completed a 
full course of IPTp related that they had not been offered 
the treatment by health workers on at least one occa-
sion, despite regular ANC attendance. With regard to 
supply-side issues, this was the only noticeable difference 
between the responses given by the women interviewed 
during the two rounds of data collection. Health workers 
did not explain to those women who did not receive IPTp 
why the service had not been offered.
Researcher: What reasons were you told for not get-
ting the tablets?
Woman 19: The nurse did not tell me why I didn’t 
receive the tablets.
Researcher: There was nothing you were told com-
pletely?
Woman 19: The nurse only examined me and there 
after she did not tell me the reason for not getting the 
tablets.
Note however, that self-reported administration of 
IPTp may be unreliable. A recent study in Uganda found 
that only about one-third of women who self-reported 
having used IPTp tested positive for SP in the blood 
stream [35].
Health workers and district officials described a num-
ber of scenarios where IPTp might not be provided. For 
example, it was suggested by one respondent that health 
workers might prioritize provision of IPT1 over provi-
sion of IPT2 when stock levels of SP are low. A district 
official speculated that some health workers might not 
provide IPTp if women initiate ANC late during their 
pregnancies—either to punish them for late attendance 
or because they think SP is not safe to be administered 
during the final weeks of pregnancy. Many health work-
ers stated that they do not offer IPTp to women who 
report having ‘reacted’ to IPTp during previous pregnan-
cies. However, from respondents’ examples, it appears 
they are referring to mild side effects rather than poten-
tially life threatening allergic reactions:
Health worker 8: We got one who said in the previ-
ous pregnancy she took it and it really worsened her 
condition – as in she started vomiting – that thing 
– and you know, so we just – what we did was to give 
her the information – ok to give her the benefits of 
taking IPTp, but we didn’t force her to take.
In the context of poor knowledge of the IPTp guidelines 
and lack of adequate training, this might reflect a lack of 
knowledge of common side effects and contra-indica-
tions of IPTp, a challenge cited in a recent study in Ghana 
[36]. In order to maximize provision of IPTp, it will be 
important to educate health workers about differentiat-
ing between mild and serious side effects. This is particu-
larly relevant as health workers frequently reported that 
women who are reluctant to take IPTp out of fear of side 
effects can be persuaded to accept the treatment if health 
workers provide information about the possible side 
effects and assure women that they are typically mild:
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Health worker 9: Of course during health education 
talks they can ask you questions. In case when some-
body develops side effects like rush and they—and in 
case somebody develop—feel sometimes nausea, but 
with the help of health information given to them, 
they accept.
Observing DOT
The majority of health workers and opinion leaders 
reported that IPTp is routinely provided under the super-
vision of midwives as DOT. However, several health 
workers reported that they sometimes do not observe 
DOT, particularly if their workload is high or if women 
request to take the tablets home because they have not 
eaten and do not want to take the medication on an 
empty stomach:
Health worker 12: Well, practically what we do is 
when these people come for antenatal, we tell them 
to take it at DOT. […] But the challenge is some 
mothers—they have come minus having breakfast. 
So they fear taking the drugs minus food. We tell 
them, “No you can take and go home, then have 
food.” But some insists they are going to take it, they 
first want to eat then they take the drugs, which is 
also right.
This practice appears to be particularly widespread in 
West Nile. A district official and two facility in-charges in 
this region confirmed that they were aware that midwives 
sometimes ask women to take the tablets at home, par-
ticularly if they are busy. This practice is problematic as 
compliance with DOT has been shown to increase IPTp 
uptake [37]. Midwives should be educated about the ben-
efits of DOT and should be reminded to strictly observe 
the guidelines.
Monitoring and evaluation
Data recording and reporting practices
Effective and consistent tracking and reporting of inter-
ventions helps to ensure policy makers, implementers, 
donors, and key stakeholders are kept informed of the 
progress towards achieving desired objectives, indicating 
the impact of current activities and identifying areas that 
require improvement [38]. While data relating to ANC 
and IPTp are routinely recorded in all facilities visited, 
the document and record review found that recording 
practices differed widely between facilities and individu-
als. For example, non-provision of IPTp is recorded using 
a variety of symbols and abbreviations, being variously 
denoted by a dash <->, a tick <✓>, <NT>, <ND>, or <N/
A> in the IPTp column of the ANC register. Similarly, 
while <NA> stands for ‘not available’ in some cases, in 
others it is used to denote ‘not applicable’ or ‘IPTp com-
pleted’ (i.e., client previously received two doses of IPTp). 
Moreover, while a tick stands for ‘IPTp given at this visit’ 
in some facilities, in others it signifies ‘IPTp was given in 
the past’. Many health workers also reported that stand-
ard HMIS recording tools, such as maternal passports 
and ANC register books, are often out of stock, requiring 
staff to use poor photocopies or manually drawn regis-
ters instead, which may be inconsistent with the standard 
tools.
Several midwives indicated that their recording and 
reporting duties significantly add to their workload. 
However, most midwives interviewed commented that 
they view data recording and reporting as routine work, 
which does not pose any significant challenges:
Health worker 5: Yes—and also with our reporting. 
[…] So it’s a daily thing—so it is something which is 
every day. So I think you cannot even forget it since 
you’ve started it and something which is in record 
that you are supposed to do it on daily basis when-
ever a mother—it’s a routine.
At the district level, aggregating facility-level data and 
reporting to the national level is the responsibility of an 
HMIS focal person or biostatistician. Facility-level data 
are entered into the District Health Information System 
(DHIS 2) online reporting tool, which connects district 
health offices with the Ministry of Health Resource Cen-
tre. The DHIS 2 data entry form automatically rejects 
certain entries as erroneous. For example, it does not 
allow the figure for provision of IPT1 to be greater than 
the one reported for ANC1 and the figure for provision 
of IPT2 must not be greater than the one reported for 
provision of IPT1 in any given month. However, all the 
scenarios rejected by the system are logically possible 
and do in fact occur quite frequently. Discussions with 
data managers at district level revealed that they resort 
to adjusting the reported figures to match the data entry 
system’s requirements when faced with this challenge, 
thereby falsifying the reports received from the facilities:
District official 7: Okay now, secondly, when we get 
it—like we—we do—we have ANC1—ANC first visit 
is 218. IPT1 is rated maybe 300. That one can’t hap-
pen. So we reduce that one to this [indicates act of 
replacing one figure for another].
Data accuracy
Both district officials and facility health workers over-
whelmingly stated that they believe facility and district-
level data to be fairly accurate. There was, however, a 
clear mismatch between health workers’ perceptions and 
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the results of the document and record review, which 
found that both under and over-reporting with regard 
to all indicators reviewed occurred in all facilities vis-
ited. In some cases, figures reported to the district var-
ied from data recorded in the facility’s register by more 
than 500 %. For example, in July 2013, a health centre II 
recorded three ANC4 visits, but reported 25 (variance of 
733 %). Similarly, in the same month, a hospital recorded 
five women who received IPT2, but reported 34 (variance 
of 580  %). While both under and over-reporting on a 
smaller scale of up to 25 % occurred very frequently, high 
variances in excess of 50  % tended to be cases where a 
much higher number was reported compared with what 
had been recorded in the register, maybe because health 
workers feel under pressure to report high uptake figures 
in an attempt to present their work in a positive light, as 
suggested by one district official:
District official 1: Then at the end of the month, 
you say, “Ah, what do I do?” That’s where I’m—the 
other—maybe the other issue of exaggerating data 
comes in. You can feel, “Ah, now, I need to be per-
forming better. Well, my mothers have been—and 
the numbers have been ok. Then this time, what 
will they think, hm?” I think that’s what I—my mind 
takes me that maybe that’s where it sometimes—you 
get these figures interchanged.
Discrepancies between recorded and reported data 
tended to be greater at higher level than at lower level 
facilities, probably because of the larger data volumes 
handled by higher level units (see Fig. 3). In comparable 
facilities, discrepancies were found to be lower in Eastern 
than in West Nile, possibly as a result of the higher levels 
of implementation partners’ support in Eastern region. 
The poor accuracy and quality of data recording found 
through the document and record review reflect the con-
clusion of WHO’s assessment of health facility data in 
Uganda [15].
Where health workers acknowledged that, on occasion, 
data inaccuracies do occur, they typically ascribed them 
to high workload:
Health worker 3: Challenges when women are very 
many, you get tired and sometimes, recording, 
you need to record, you need to go for other things, 
examinations.
Poor data management skills and lack of training were 
also mentioned. Some respondents pointed out that non-
compliance with DOT might obscure actual IPTp uptake 
figures, as women might not actually take SP, while health 
workers are likely to record provision of IPTp in the reg-
ister. Many health workers noted that data accuracy did 
not appear to be seen as a priority, as the criteria used for 
assessing facilities’ monthly data reports at the district 
level are promptness and completeness. Districts do not 
commonly provide feedback to the facilities with regard 
to the accuracy of recorded data submitted.
The results presented above suggest that coverage rates 
recorded and reported should be treated with caution, as 
there appear to be sources of error and inaccuracy along 
the recording and reporting chain. In Uganda, poor data 
quality and reporting practices have been identified as 
important challenges to effective monitoring and evalu-
ation of malaria interventions [11] and HMIS has been 
singled out as a priority area requiring improvement [39]. 
Furthermore, it should be noted that there is currently no 
Fig. 3 Reporting variance for the provision of IPT2 in four health facilities, May–October 2012 and May–October 2013
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system for collecting and integrating data from the pri-
vate sector into HMIS [11].
Conclusions
This research confirmed that a range of supply-side 
issues continue to impede uptake of IPTp in Uganda. 
While most barriers to IPTp uptake discussed by the dif-
ferent types of respondents applied equally in both study 
regions, where differences between the regions were evi-
dent, for example, with regard to reserving SP for IPTp 
and observing DOT, supply-side issues appeared more 
pronounced in West Nile than in Eastern region. This 
probably reflects the lower levels of implementation part-
ner support this region has received.
There was a high level of agreement on supply-side 
barriers among all target audiences. District health offi-
cials tended to emphasize issues relating to stakeholder 
coordination, provision of ANC and the supply chain, 
whereas health workers tended to highlight a lack of 
training opportunities. Women and opinion leaders on 
the other hand stressed the negative impact of health 
workers refusing services to women attending ANC. 
Most challenges were mentioned to a greater or lesser 
extent by all target audiences however, and the design 
of the question guides for the different target audiences 
anticipated priority challenges for each type of respond-
ent, which may have biased responses with regard to the 
relative importance attached to specific issues. It was also 
noticeable that there was generally a lack of awareness of 
conflicting IPTp guidelines by district level officials and 
health workers and an inadequate knowledge of guide-
lines by health workers.
The document and record review revealed that, con-
trary to district officials’ and health workers’ perceptions, 
data recording and reporting may be poor, with sources 
of errors along the recording and reporting chain. This 
limits policy makers’ and service providers’ ability to 
assess the scope of the problem and react appropriately 
to trends and challenges.
Based on the results of this study, the following actions 
are recommended to overcome key supply-side barriers:
  • Stakeholders and coordination Governments and 
implementation partners should increase efforts 
to build strong linkages and improve integration in 
order to ensure that health programmes reach those 
most in need.
  • Policies and guidelines In its latest policy recom-
mendation, WHO acknowledges that “confusion 
among health workers” contributed to a slowing 
down of efforts to scale up IPTp and expresses the 
hope that the new simplified guidelines will help 
increase uptake of IPTp through avoiding ambigu-
ity in terms of number of doses required and ideal 
timing [16]. While Uganda adopted this recommen-
dation in May 2016, ensuring that health workers 
are aware of the policy change and implement it in 
their day-to-day job should be treated as a matter of 
priority. In the light of reports of preferential treat-
ment for women attending with their partners, the 
national-level policy, which encourages male ANC 
attendance, should be clarified, emphasizing the 
imperative to provide ANC services to all women 
equally, regardless of whether or not they attend 
with their partner.
  • Provision of ANC services ANC should be offered 
consistently at all suitable health facilities in line 
with national policy. Governments must provide 
for adequate staffing levels, but health workers also 
need to observe professional and respectful behav-
iour towards all ANC clients and ensure all pregnant 
women attending ANC have equal access to ser-
vices. In particular, this applies to women who miss 
appointments, present late for ANC or are perceived 
to be inadequately dressed. Early and regular ANC 
attendance should be encouraged through the provi-
sion of incentives, such as mosquito nets.
  • Supply chain While only one PNFP facility was vis-
ited and this type of service provider was therefore 
under-represented in the sample, the issue of persist-
ing stock-outs of SP in PNFP facilities was confirmed 
more widely by district health officials. In the interest 
of equity, the Government should enable PNFP facili-
ties to offer IPTp to pregnant women by providing SP 
free-of-charge. In addition to ensuring IPTp is pro-
vided to women who attend ANC, ensuring availabil-
ity of SP will also positively influence communities’ 
attitudes towards ANC and hence help to maintain 
high ANC uptake.
  • Capacity building and health worker knowledge and 
perceptions of IPTp To improve health worker knowl-
edge of IPTp guidelines, opportunities for train-
ing and supervision should be intensified. Train-
ing should emphasize that it is safe to take SP on an 
empty stomach and that women should be encour-
aged to take IPTp as DOT, even if they ask to take the 
drug home, for example, because they have not eaten. 
Clear guidance with regard to distinguishing between 
mild and severe side effects should be provided, 
emphasizing that women should still be encouraged 
to take SP if they have previously experienced mild 
side effects. Taking into account health workers’ pref-
erence for non-disruptive training, innovative meth-
ods such as peer learning, mentoring or the use of 
mobile technology should be trialled in addition to 
traditional classroom training.
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  • Monitoring and evaluation In order to improve the 
quality and reliability of data relating to ANC and 
IPTp at the facility and district level, supply of stand-
ard recording and reporting tools to all health facili-
ties needs to be ensured. It will also be necessary to 
improve health workers’ data management skills, 
provide clear guidelines with regard to recording 
practices and ensure data entry forms are designed to 
capture all plausible scenarios. In addition to assess-
ing completeness and timeliness of reported facility-
level data, districts should also provide feedback with 
regard to data accuracy.
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